GB9811312D0 - Method of treatment with an angiotensin II antagonist - Google Patents

Method of treatment with an angiotensin II antagonist

Info

Publication number
GB9811312D0
GB9811312D0 GBGB9811312.9A GB9811312A GB9811312D0 GB 9811312 D0 GB9811312 D0 GB 9811312D0 GB 9811312 A GB9811312 A GB 9811312A GB 9811312 D0 GB9811312 D0 GB 9811312D0
Authority
GB
United Kingdom
Prior art keywords
angiotensin
antagonist
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9811312.9A
Other versions
GB2337701A (en
GB2337701A8 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guys and St Thomas NHS Foundation Trust
Original Assignee
Guys and St Thomas NHS Foundation Trust
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guys and St Thomas NHS Foundation Trust filed Critical Guys and St Thomas NHS Foundation Trust
Priority to GB9811312A priority Critical patent/GB2337701A/en
Publication of GB9811312D0 publication Critical patent/GB9811312D0/en
Publication of GB2337701A publication Critical patent/GB2337701A/en
Publication of GB2337701A8 publication Critical patent/GB2337701A8/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
GB9811312A 1998-05-26 1998-05-26 Treatment of ischemia with an angiotensin II antagonist Withdrawn GB2337701A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9811312A GB2337701A (en) 1998-05-26 1998-05-26 Treatment of ischemia with an angiotensin II antagonist

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9811312A GB2337701A (en) 1998-05-26 1998-05-26 Treatment of ischemia with an angiotensin II antagonist

Publications (3)

Publication Number Publication Date
GB9811312D0 true GB9811312D0 (en) 1998-07-22
GB2337701A GB2337701A (en) 1999-12-01
GB2337701A8 GB2337701A8 (en) 2000-02-22

Family

ID=10832733

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9811312A Withdrawn GB2337701A (en) 1998-05-26 1998-05-26 Treatment of ischemia with an angiotensin II antagonist

Country Status (1)

Country Link
GB (1) GB2337701A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE509014T1 (en) 2001-01-26 2011-05-15 Chugai Pharmaceutical Co Ltd MALONYL COA-DECARBOXYLASE INHIBITORS AS METABOLISM MODULATORS
WO2002058690A2 (en) 2001-01-26 2002-08-01 Chugai Seiyaku Kabushiki Kaisha Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
ATE341539T1 (en) 2001-01-26 2006-10-15 Chugai Pharmaceutical Co Ltd MALONYL COA-DECARBOXYLASE INHIBITORS AS METABOLISM MODULATORS
US7709510B2 (en) 2001-02-20 2010-05-04 Chugai Seiyaku Kabushiki Kaisha Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
EP1379243B1 (en) 2001-02-20 2009-09-09 Chugai Seiyaku Kabushiki Kaisha Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors
CA2533881C (en) 2003-08-01 2012-07-10 Chugai Seiyaku Kabushiki Kaisha Cyanoguanidine-based azole compounds useful as malonyl-coa decarboxylase inhibitors
ES2295930T3 (en) 2003-08-01 2008-04-16 Chugai Seiyaku Kabushiki Kaisha CIANOAMIDE COMPOUNDS USED AS MALONIL-COA DESCARBOXYLASE INHIBITORS.
EP1653944B1 (en) 2003-08-01 2010-11-10 Chugai Seiyaku Kabushiki Kaisha Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors
US7449482B2 (en) 2003-08-01 2008-11-11 Chugai Seiyaku Kabushiki Kaisha Piperidine compounds useful as malonyl-CoA decarboxylase inhibitors
EP2525795B1 (en) 2010-01-19 2015-10-21 Spinifex Pharmaceuticals Pty Ltd Methods and compositions for improved nerve conduction velocity
AR108906A1 (en) 2016-06-29 2018-10-10 Bristol Myers Squibb Co BIARILMETILE HETEROCICLES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997021436A1 (en) * 1995-12-12 1997-06-19 Merck & Co., Inc. New use for losartan
US5795904A (en) * 1996-12-06 1998-08-18 Merck & Co., Inc. Enhanced functional recovery of the heart by losartan treatment after an ischemic attach
US6306826B1 (en) * 1997-06-04 2001-10-23 The Regents Of The University Of California Treatment of heart failure with growth hormone

Also Published As

Publication number Publication date
GB2337701A (en) 1999-12-01
GB2337701A8 (en) 2000-02-22

Similar Documents

Publication Publication Date Title
GB9824436D0 (en) Methods of treatment
HK1047432A1 (en) Hemisynthetic method and new compounds
HU0001471D0 (en) New method of treatment
PL342076A1 (en) Method of treating surfaces
GB9811312D0 (en) Method of treatment with an angiotensin II antagonist
PL341667A1 (en) Method of treating cooped
PL342666A1 (en) Method of testing therapeutic agents
IL139943A0 (en) Method of treatment
EP1112250A4 (en) Therapeutic compounds and methods
HU9900436D0 (en) Installation and method for the treatment of wine-production efilvents
HK1041202A1 (en) Novel method of treatment
GB9822681D0 (en) Method of treatment
EP1143998A4 (en) Treatment of hypertension
GB9818776D0 (en) Method of treatment
GB9811961D0 (en) Method of treatment
GB9822459D0 (en) Method of treatment
GB9808479D0 (en) Method of treatment
EP1150967A4 (en) Therapeutic compounds and methods
GB9824208D0 (en) Methods of treatment
GB9800707D0 (en) Methods of treatment
GB9603301D0 (en) Polymorphic forms of an angiotensin II antagonist
PL333334A1 (en) Method of obtaining silylethenes
GB9915597D0 (en) Method of treatment
GB9903950D0 (en) Method of treatment
TJ99000556A (en) Method of treatment of nevrodermite

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)